Hallucinogenic N-methylated indolealkylamines in the cerebrospinal fluid of psychiatric and control populations.
L Corbett, S T Christian, R D Morin, F Benington, J R Smythies
The British journal of psychiatry : the journal of mental science February 1, 1978 DOI: 10.1192/bjp.132.2.139 (opens in new tab) via PubMed
Study at a glance
AI-extracted from the abstract| Characteristics | Observational cohort Peer reviewed |
|---|---|
| Population | Patients with acute schizophrenia and surgical and neurological controls |
| Citations | 49 |
| Key findings | Some schizophrenic patients have higher levels of dimethyltryptamine and O-methylbufotenine in cerebrospinal fluid than controls, but the differences did not reach statistical significance. |
Abstract
The incidence and quantities of dimethyltryptamine and O-methylbufotenine were studied in the cerebrospinal fluid of patients suffering acute schizophrenic illnesses and in surgical and neurological control groups. Some schizophrenic patients have higher levels of both amines than do controls, though the differences in distribution did not reach statistical significance in the sample studied. The gas-chromatographic technique used is sensitive at the low picogram level.